Gemini Security Solutions Joins SAFE-BioPharma Association Vendor Partner Program

Pledges to lead the development, implementation and adoption of SAFE standards across the biopharmaceutical sector.

Chantilly, VA (PRWEB) March 5, 2008 -- Gemini Security Solutions, a leading provider of impartial information security consulting services, announced today that it has joined the SAFE™ Signatures and Authentication for Everyone) BioPharma Association Vendor Partner Program.

The non-profit SAFE-BioPharma Association was founded by many of the world's leading pharmaceutical companies to develop the SAFE digital identity and signature standard. The SAFE standard provides users with a secure, enforceable, and regulatory compliant way to verify identities of parties involved in electronic transactions and to apply their digital signatures to electronic documents. By using SAFE digital signatures companies are able to dispense with paper originals and other cumbersome forms of back up.

Gemini Security Solutions has also been engaged by SAFE to provide technical liaison and project management expertise to the Association.

"We are pleased to be given this opportunity to be directly supporting SAFE's mission of delivering unique electronic identity credentials for legally enforceable and regulatory compliant digital signatures across the global biopharmaceutical environment," said Peter Hesse, President and Founder, Gemini Security Solutions. "We have focused significant energy toward helping corporations realize the benefits of digital signatures and identity management standards to safeguard critical information. We are excited to be recognized both as a SAFE partner and a trusted technical expert."

"The biopharmaceutical sector faces unique regulatory and security pressures that drive the adoption of simplified, secure and streamlined information exchange," said Mollie Shields-Uehling, President and CEO SAFE-BioPharma Association. "We are glad to welcome Gemini Security Solutions and its team of professionals to SAFE's Vendor Partner Program."

As a SAFE partner, Gemini Security Solutions brings a wealth of expertise in the security consulting, system administration, and software development fields for a variety of large corporations focused on life sciences. Through proven experience with FDA-validated systems and compliance assessment programs, Gemini brings a unique understanding of the business processes and regulatory requirements inherent in this unique industry.

About Gemini Security Solutions, Inc.
Gemini Security Solutions (www.geminisecurity.com) provides impartial information security consulting services that ensure the confidentiality, integrity, and availability of critical business information and resources.

Founded in 2001, and with decades of experience, Gemini Security Solutions' certified team of experts assists organizations with the assessment and delivery of security solutions in compliance with business strategy, policy and regulatory requirements. Their services include risk analysis and management, regulatory compliance, identity management, operations security, and security software development.

Gemini Security Solutions is focused on providing big business experience with a small business approach. Working with its clients every step of the way, Gemini Security Solutions enables secure business operations with vigor, agility and a commitment to excellence.

About SAFE-BioPharma Association
SAFE-BioPharma Association is the non-profit association that created and manages the SAFE™ digital identity and d signature standard for the pharmaceutical and healthcare industries. The SAFE standard is used to mitigate legal, regulatory and other business risk associated with business-to-business and business-to-regulator electronic transactions. It facilitates interoperability between disparate information systems by providing a secure, enforceable, and regulatory-compliant way to verify identities of parties involved in electronic transactions. SAFE's vision is to be a catalyst in transforming the biopharmaceutical and healthcare communities to a fully electronic business environment by 2012. The Association's members include Amgen, AstraZeneca, Bristol-Myers Squibb, Genzyme, GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer, Procter & Gamble, Roche and Sanofi-Aventis. For more information, visit www.safe-biopharma.org.

SAFE™ is a trademark of SAFE-BioPharma Association. Any use of this trademark requires approval from SAFE Bio-Pharma Association.

###